Science Explorer Interactive view Map
Company · Davis · United States

Arcadia Biosciences (United States)

arcadiabio.comROR OpenAlex
Research works
14
▼ 19% vs 2013–17
Citations
884
61.2 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
60%
world 28%

Not ranked overall: Arcadia Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.29× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.82× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 15.22× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 14.49× its world share, 0 worksPharmacology, Toxico…Chemistry: 9.76× its world share, 0 worksChemistryMedicine: 2.80× its world share, 1 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.2×. Every wedge is a field page.

Which research topics does Arcadia Biosciences (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and Synthetic Organic Chemistry Methods.

CAR-T cell therapy research: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksImmune Cell Function and…0Immune Cell Function and Interaction: 0 fractional worksSynthetic Organic Chemis…0Synthetic Organic Chemistry Methods: 0 fractional worksAsymmetric Hydrogenation…0Asymmetric Hydrogenation and Catalysis: 0 fractional worksCancer Treatment and Pha…0Cancer Treatment and Pharmacology: 0 fractional worksOcular Surface and Contact Lens: 0 fractional worksAdvanced Drug Delivery Systems: 0 fractional worksGlaucoma and retinal disorders: 0 fractional worksCeliac Disease Research and Management: 0 fractional works
OncologyImmunologyOrganic ChemistryInorganic Chemistry4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 0 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 0 works
  3. 3 Immune Cell Function and Interaction Immunology 0 works
  4. 4 Synthetic Organic Chemistry Methods Organic Chemistry 0 works
  5. 5 Asymmetric Hydrogenation and Catalysis Inorganic Chemistry 0 works
  6. 6 Cancer Treatment and Pharmacology Oncology 0 works
  7. 7 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
  8. 8 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  9. 9 Glaucoma and retinal disorders Ophthalmology 0 works
  10. 10 Celiac Disease Research and Management Gastroenterology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.5%not open40.5%

World: 28% of research is openly available.

with international co-authors22.6%domestic only77.4%

World: 19% is written across borders.

How has Arcadia Biosciences (United States)'s research output changed?

Output in 2018–2022 was 19% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Davis

All research institutions in Davis

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.